ERG Regulates Lymphatic Vessel Specification Genes and Its Deficiency Impairs Wound Healing‐Associated Lymphangiogenesis
- 7 August 2024
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatology
- Vol. 76 (11) , 1645-1657
Abstract
Objective: Rarefaction of blood and lymphatic vessels in the skin has been reported in systemic sclerosis (SSc) (scleroderma). E26 transformation–specific–related factor (ERG) and Friend leukemia virus–induced erythroleukemia 1 (FLI‐1) are important regulators of angiogenesis, but their role in lymphatic vasculature is lesser known. The goal of this study was to determine the role of ERG and FLI‐1 in postnatal lymphangiogenesis and SSc lymphatic system defects.Methods: Immunofluorescence was used to detect ERG and FLI‐1 in skin biopsy samples from patients with SSc and healthy controls. Transcriptional analysis of ERG or FLI‐1–silenced human dermal lymphatic endothelial cells (LECs) was performed using microarrays. Effects of ERG and FLI‐1 deficiency on in vitro tubulogenesis in human dermal LECs were examined using a Matrigel assay. ERG and FLI‐1 endothelial–specific knockouts and ERG lymphatic–specific knockouts were generated to examine vessel regeneration in mice.Results: ERG and FLI‐1 protein levels were reduced in the blood and lymphatic vasculature in SSc skin biopsy samples. ERG levels were shown to regulate genes involved in lymphatic vessel specification, including vascular endothelial growth factor receptor 3/FLT‐4, lymphatic vessel endothelial hyaluronan receptor 1, SOX‐18, and prospero homeobox 1 (PROX‐1), whereas FLI‐1 enhanced the function of ERG. The ERG–FLT‐4 pathway regulated in vitro tubulogenesis in human LECs. Deficiency of ERG or FLI‐1 similarly impaired the function of blood vessels in mice. However, only ERG deficiency affected the regeneration of lymphatic vessels during wound healing.Conclusion: ERG and FLI‐1 are essential regulators of blood and lymphatic vessel regeneration. Deficiency of ERG and FLI‐1 in SSc endothelial cells may contribute to the impairment of blood and lymphatic vasculature in patients with SSc. imageKeywords
Funding Information
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (2P50 AR060780, AR080950)
This publication has 39 references indexed in Scilit:
- LGR5 expressing skin fibroblasts define a major cellular hub perturbed in sclerodermaCell, 2022
- Association of Lymphangiogenic Factors With Pulmonary Arterial Hypertension in Systemic SclerosisArthritis & Rheumatology, 2021
- Altered Properties of Endothelial Cells and Mesenchymal Stem Cells Underlying the Development of Scleroderma‐like Vasculopathy in KLF5+/−;Fli‐1+/− MiceArthritis & Rheumatology, 2020
- The Lymphatic Vasculature in the 21st Century: Novel Functional Roles in Homeostasis and DiseaseCell, 2020
- ETS transcription factors in embryonic vascular developmentAngiogenesis, 2016
- Vasculopathy in sclerodermaSeminars in Immunopathology, 2015
- The Endothelial Transcription Factor ERG Promotes Vascular Stability and Growth through Wnt/β-Catenin SignalingDevelopmental Cell, 2015
- Review: Evidence That Systemic Sclerosis Is a Vascular DiseaseArthritis & Rheumatism, 2013
- Decreased lymphatic vessel counts in patients with systemic sclerosis: Association with fingertip ulcersArthritis & Rheumatism, 2010
- Vascular Disease in SclerodermaClinical Reviews in Allergy & Immunology, 2008